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Abstract 
Background: We evaluated the role that selected variants in serotonin transporter (5-HTT), 
dopamine receptor 2 (DRD2) and brain-derived neurotrophic factor (BDNF) genes play in 
PTSD symptom severity in an at-risk population. We also investigated the interaction 
between the genetic variants to determine whether these variables and the interactions 
between the variables inﬂuenced the severity of PTSD symptoms. 
Methods: PTSD symptoms were quantitatively assessed using the Davidson Trauma Scale 
(DTS) in 150 participants from an at-risk South African population. All participants were 
genotyped for the 5-HTTLPR, DRD2 Taq1A and BDNF  Val66Met polymorphisms. Gene–
gene interactions were investigated using various linear models. All analyses were adjusted 
for age, gender, major depressive disorder diagnosis, level of resilience, level of social 
support and alcohol dependence. 
Results: A signiﬁcant interaction effect between DRD2 Taq1A and BDNF Val66Met 
variants on DTS score was observed. On the background of the BDNF Val66Val genotype, 
DTS score increased signiﬁcantly with the addition of a DRD2 Taq1A A1 allele. However, on 
the BDNF Met66 allele background, the addition of an A1 allele was found to reduce total 
DTS score. 
Conclusions: This study provides preliminary evidence for an epistatic interaction between 
BDNF Val66Met and DRD2 Taq1A polymorphisms on the severity of PTSD symptoms, 
where both too little and too much dopamine can result in increased PTSD symptom 
severity. 
 
1. Introduction 
Posttraumatic stress disorder (PTSD) is an anxiety disorder that develops following exposure 
to a life-threatening event (APA, 1994). However, not all trauma-exposed individuals 
develop PTSD. The lifetime prevalence of exposure to traumatic events varies between 40% 
and 90%, depending on the sample investigated, whereas the lifetime prevalence of PTSD in 
trauma-exposed individuals has been estimated at approximately 9% (Breslau et al., 2012). 
Numerous risk factors for developing PTSD have been elucidated, including those 
pertaining to the traumatic event, such as type, severity and duration of trauma, poor 
social support and childhood adversity (reviewed in Yehuda and LeDoux, 2007). In addition, 
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twin and family studies have indicated that genetics plays an important role in the 
development of PTSD, with heritability estimates between 30% and 40% (Sack et al., 1995; 
Stein et al., 2002; True et al., 1993; Yehuda et al., 1998, 2001, 2002). Although a number of 
candidate gene association studies have been conducted to identify susceptibility variants 
playing a role in the aetiology of PTSD (reviewed in Cornelis et al., 2010), no gene variant 
has yet been reported as being unequivocally involved in the development of the disorder. 
One of the reasons for the inconclusive results may be that few studies have accounted for 
environmental factors that potentially inﬂuence the development of PTSD. In addition, to 
date, no studies have investigated the potential effects that interactions between genetic 
variants may have on inﬂuencing susceptibility to PTSD. 
 
The most widely studied polymorphism in PTSD genetics is one that occurs in the promoter 
region of the gene encoding the serotonin transporter (5-HTT), which plays a crucial role in 
regulating serotonergic activity in the synapse. The 5-HTT-linked polymorphic region (5-
HTTLPR) is a 44 base pair (bp) insertion/deletion polymorphism characterised by either 
14 (short, S) or 16 (long, L) copies of an imperfect 22–23 bp repeat (Heils et al., 1996; Lesch 
et al., 1996). The S allele has been found to possess transcriptional activity two to three fold 
lower than that of the L allele (Lesch et al., 1996). Of the ten candidate gene association 
studies that have investigated the role that 5-HTTLPR plays in the development of PTSD, ﬁve 
have yielded significant associations between the lower-expressing allele (S allele) and PTSD 
(Kilpatrick et al., 2007; Koenen et al., 2009; Kolassa et al., 2010; Lee et al., 2005; Xie et al., 
2009). However, three studies yielded results implicating  the higher-expressing  allele (L 
allele)  in  the pathogenesis of PTSD (Grabe et al., 2009; Sayin et al., 2010; Thakur et al., 
2009), while two studies did not ﬁnd any association between 5-HTTLPR and PTSD 
(Mellman et al., 2009; Valente et al., 2011). 
 
A number of lines of evidence implicating dopamine in the development of PTSD also exist. 
Dopamine has been detected at elevated amounts in urine and plasma samples from PTSD 
patients compared to controls (Hamner and Diamond, 1993; Lemieux and Coe, 1995; Yehuda et 
al., 1992). The dopamine receptor 2 gene (DRD2) possesses a potentially functional single 
nucleotide polymorphism (SNP), DRD2 Taq1A (rs1800497), in the 3′UTR (Grandy et al., 
1989). The SNP comprises two alleles, namely a T allele, known historically as the A1 allele, and 
a C allele, known historically as the A2 allele. For the sake of parity with previous publications, 
the current study will make use of the A1/A2 allelic nomenclature. Numerous studies have 
indicated that A1 allele carriers exhibit a reduced number of DRD2 in the brain (Jonsson et al., 
1999; Noble et al., 1991; Pohjalainen et al., 1998; Ritchie and Noble, 2003; Thompson et al., 
1997) and increased rates of dopamine synthesis rates in the striatum (Laakso et al., 2005). The 
DRD2 Taq1A variant has been investigated for its role in the development of PTSD in a number 
of studies, with inconsistent results. A signiﬁcant association has been observed between the A1 
allele and PTSD in a cohort of European American Vietnam war veterans (Comings et al., 
1996), although these results were not replicated in a subsequent study (Gelernter et al., 1999). 
On the other hand, Young et al. (2002) observed an association between the A1 allele and 
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PTSD, but this association was only observed in patients with PTSD who were classiﬁed as 
‘harmful drinkers’ (i.e. consuming >60 g alcohol/day). In a more recent study, Bailey et al. 
(2010) found no association between DRD2 Taq1A and PTSD. 
 
Brain-derived neurotrophic factor (BDNF) has also been implicated in the development of 
PTSD. BDNF is widely expressed throughout the mammalian brain, and is involved in 
neurodevelopment, neuronal  survival,  neuronal  morphology  and  differentiation,  synaptic 
plasticity and protection against stress-induced neuronal damage (Bergstrom et al., 2008; 
Duman and Monteggia, 2006; Hoglinger et al., 1998; Huang and Reichardt, 2001; Lu, 2003; 
Poo, 2001). There is also evidence from animal studies that psychological or physical 
stress, or both, may inhibit hippocampal BDNF expression (Duman et al., 1997, 2000; 
Kozlovsky et al., 2007; Smith et al., 1995). In addition, serum levels of BDNF have been found 
to be decreased in individuals with PTSD compared to healthy controls (Dell'osso et al.,  
2009). Karege et al. (2002) previously demonstrated a correlation between levels of BDNF in 
the serum and central nervous system (CNS). A SNP in the BDNF gene (Val66Met; rs6265) has 
been found to affect dendritic trafﬁcking, synaptic localisation and activity-dependent 
secretion of BDNF (Chen et al., 2006; Egan et al., 2003). Individuals who carry the Met66 allele 
have been found to exhibit poorer episodic memory and abnormal hippocampal activation 
(Egan et al., 2003), as well as reduced hippocampal volumes (Bueller et al., 2006; Hajek et al., 
2012; Montag et al., 2009; Pezawas et al., 2004), often observed in patients with PTSD 
(Bremner et al., 1997, 2008; Sapolsky, 2000). The BDNF Met66 allele has also been found to 
be associated with impaired fear extinction in both a mouse model and human cohort 
(Soliman et al., 2010; Yu et al., 2009). Although previous studies found no association between 
BDNF Val66Met and PTSD (Lee et al., 2006; Valente et al., 2011; Zhang et al., 2006), 
sample sizes were relatively small in these studies, and none  of them accounted for gene–
gene interactions, warranting further investigation. 
 
The sample in the present study was drawn from four communities of low socioeconomic status 
in the Western Cape, namely Ravensmead, Uitsig, Adriaanse and Elsies River. A large 
proportion of the residents from these areas are unemployed, and those that are employed 
receive annual incomes of between R19,201 (US equivalent $2300) and R76,800 (US 
equivalent $9183). In addition to being very poor, these areas have a very high tuberculosis 
(TB) incidence (Kritzinger et al., 2009). Crime and violence are also common in this area. 
Ravensmead has been named as a “high-risk area” for gang-related serious violent crime by 
the Western Cape Organised Crime Unit of the South African Police Service (SAPS) (Kagee and 
Frank, 2005). Dinan et al. (2004) found that South African women from a similarly low 
socioeconomic area characterised by high levels of both domestic and community violence 
reported a median of three traumatic incidences in the previous 12-month period. Moreover, a 
PTSD rate of 25.8%, as assessed by a self-report measure of PTSD, has previously been 
documented in a study conducted in an urban community sample of adult victims of violent 
crime in South Africa (Peltzer, 2000). The aforementioned rate of PTSD is considerably 
higher than that found in the recently conducted South African Stress and Health (SASH) 
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study. The SASH study, which was conducted among a national representative sample of 4351 
adults, reported an estimated 12-month prevalence for PTSD of 0.6%, with an estimated 
lifetime prevalence rate for PTSD of 2.3% (Herman et al., 2009). Thus, the study population 
represents a population at high risk for experiencing trauma and for developing subsequent 
stress-related  disorders. 
 
The aim of the current study was to determine whether genetic factors play a role in the 
development and severity of PTSD symptoms in a population that is at high risk for 
experiencing trauma. To this end, we investigated the association between speciﬁc alleles or 
genotypes of (1) 5-HTTLPR, (2) DRD2 Taq1A and (3) BDNF Val66Met and trauma 
symptom severity in a vulnerable population. We also investigated whether epistatic 
interactions between the genetic variants inﬂuenced trauma symptom severity. 
 
2. Methods 
2.1 Participants 
One hundred and ﬁfty participants were drawn from an ongoing study investigating the 
effect of psychological stress on the development of TB in close contacts of TB patients 
(unpublished data). All participants were trauma-exposed, close household contacts of 
patients with active TB disease, diagnosed through four community health clinics in the 
Cape Town area. The participants were all non-TB cases, and all identiﬁed themselves as 
Coloured (mixed race). The protocol was approved by the Health Research Ethics Committee at 
Stellenbosch University, and all subjects provided written, informed consent after being 
presented with a complete description of the study. 
 
2.2 Measurements: demographic characteristics 
A researcher-administered questionnaire was used to collect information on participants' 
age, marital status, level of education, annual household income and employment status. 
 
2.3 Clinical measures 
Psychiatric morbidity, including PTSD, was assessed using the Mini-International 
Neuropsychiatric Interview (M.I.N.I.) (Sheehan et al., 1998), a clinician-administered, 
structured diagnostic interview for major psychiatric disorders based on the DSM-IV 
diagnostic criteria. 
 
The 18-item Traumatic Life Events Checklist (LEC) was used to identify exposure to potentially 
traumatic events that participants may have directly experienced, witnessed or learned about. 
Once the most traumatic event was speciﬁed by the participant, the Davidson Trauma Scale 
(DTS) (Davidson et al., 1997) was administered to those participants who endorsed trauma 
exposure so as to determine the severity of posttraumatic stress symptoms. The DTS is a 17-
item self-report measure that assesses both the frequency and intensity of PTSD symptoms 
among individuals with a history of trauma exposure. Items are measured on a 5-point Likert-
type scale, ranging from 0 (‘not at all’) to 4 (‘every day/extreme’), with higher scores 
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depicting more severe PTSD symptoms. A total score of greater than, or equal to, 40 has been 
found to most accurately predict clinical diagnosis of PTSD (Davidson et al., 1997). 
 
Perceived social support was assessed using the Multidimensional Scale of Perceived Social 
Support (MSPSS) (Zimet et al., 1988), a 12-item, self-report measure that assesses 
perceptions of social support from three sources, namely family, friends and signiﬁcant others. 
The items are measured on a 7-point scale, ranging from 1 (‘very strongly disagree’) to 7 
(very strongly agree), with higher scores indicating a greater degree of social support. Because 
social support has been found to represent a risk/resiliency factor in PTSD (Brewin et al., 
2000; Ozer et al., 2003), it was necessary to assess and correct for this variable. 
 
Resilience was measured using the Connor–Davidson Resilience Scale (CD-RISC) (Connor 
and Davidson, 2003). This is a 25-item self-report scale that measures stress coping ability. 
Items are measured on a 5-point scale from 0 (‘not true at all’) to 4 (‘true nearly all of the 
time’). A total score between 0 and 100 is obtained, with higher scores indicating increased 
resilience. 
 
2.4. Genotyping 
DNA was extracted from whole blood, using the Nucleon BACC3 Illustra extraction kit (GE 
Healthcare). The loci containing each of the polymorphisms were ampliﬁed individually, 
using previously published primers (Baune et al., 2008; Grandy et al., 1993; Sen et al., 
2003). Thermal cycling was performed in a GeneAmp® PCR system 9700 (Perkin Elmer 
Biosystems, Foster City, CA, USA) for 30 cycles for all polymorphisms. The annealing 
temperatures and length of the PCR-ampliﬁed product for each set of oligonucleotide 
primers are presented in Table 1. 
 
The long allele (L) of 5-HTTLPR is characterised by a size of 528 bp, while the short allele (S) is 
characterised by a size of 484 bp (Table 1). The 5-HTTLPR amplicons were electrophoresed 
on 2% ethidium bromide-stained agarose gels, and sized accordingly. Allele-speciﬁc 
restriction enzyme analysis (ASREA) was performed to characterise the genotypes arising 
from the DRD2 Taq1A and BDNF Val66Met polymorphisms as follows. 
 
For DRD2 Taq1A, the 310 bp amplicon was digested overnight at 65 °C with 10 U of Taq1 
(New England Biolabs, Beverly, MA, USA). The restriction enzyme recognizes a site in the A2 
allele, resulting in two DNA fragments of 130 bp and 180 bp, whereas the A1 allele remains 
uncut as a 310 bp fragment. DRD2 Taq1A alleles were visualised on 2% agarose gels, 
stained with ethidium bromide. For BDNF Val66Met, the 274 bp amplimer was digested 
with 5U NlaIII (New England Biolabs, Beverly, MA, USA) overnight at 37 °C. Two NlaIII 
restriction enzyme sites are present in the ampliﬁed genomic fragment. The ﬁrst site is cut 
constitutively and produces fragment sizes of 57 bp and 217 bp, whereas at the polymorphic 
site, NlaIII cuts the A (Met66) allele, generating fragments of 140 bp, 77 bp and 57 bp in 
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size, while the G (Val66) allele remains uncut. BDNF Val66Met alleles were visualised on 
3% agarose gels, stained with ethidium bromide. 
 
2.5. Statistical analysis 
Data was summarised as median (interquartile range [IQR]) for all quantitative variables, as 
most had very skewed, and therefore non-normal, distributions. Categorical traits, including  
genotypes, were summarised as counts and percentages for the study group as a whole, and for 
males and females separately. The appropriate unadjusted tests provided the p-values for sex 
differences in the variables. 
 
The DTS scores did not possess a standard distribution, as a preponderance of zeros was 
observed (53 [35%]). To obtain valid results, a zero-inﬂated analysis model was required 
(Zeileis et al., 2008). This analysis represents a mixture of two models: one model ﬁts a 
count distribution to the data, the second (binomial) makes a percentage of those values 
zero. We used a zero-inﬂated model with a negative binomial family for the (non-zero) 
counts. 
 
Genetic association and interactions were tested by including single genotype and genotype-
by-genotype interaction terms, respectively, as categorical ﬁxed effects in the models. 
Interaction terms that were not signiﬁcant were removed from the models. When 
inspection of genotype effects indicated that the heterozygote and the minor homozygote 
had similar effects, a dominant coding of the genotype was tested. 
 
The analysis was adjusted for known confounders, namely age, sex, the presence or absence of 
major depression, alcohol dependence, resilience, social support, and levels of education and 
employment. These confounders were adjusted for by including them in the statistical 
models as ﬁxed effects. The analysis yields two sets of results, corresponding to the mixture of 
two models, for each factor (confounders and polymorphisms investigated): ﬁrst, whether it 
affects the zero or non-zero status of DTS, and second, what the count is, if it is not zero. The 
signiﬁcance of effects (p-values) and effect sizes (% differences) are part of the results of the 
confounder-adjusted zero-inﬂated models used in the analyses. 
 
Statistical analyses were done with functions from R (www.r-project.org), and R packages 
genetics (genotype and allelic counts and frequencies; Hardy-Weinberg equilibrium testing) 
and pscl (zero-inﬂated modelling). 
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3. Results 
3.1. Demographic and clinical measures 
Table 2 summarises the demographic and clinical variables measured in the total study 
group, and stratiﬁed by sex. Thirty-one percent (47/150) of the study group was male. The 
median age of the group was 30.5 years (IQR: 23–42 years), with no signiﬁcant differences 
observed between male and female participants (p= 0.440). Fifty-nine participants (39.3%) 
possessed an education level of Grade 8 (equivalent to ten years of schooling) or less, and no 
signiﬁcant differences were observed with regard to level of education between male and 
female participants (p= 0.858). Only 32.7% of the participants were employed, with 
signiﬁcantly more males being employed (pb 0.001). More than half of the participants 
reported an annual income of less than R10,000 (US equivalent $1205), indicating that the 
majority were living in poverty. 
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According to the M.I.N.I, seventeen participants met the criteria for current PTSD diagnosis 
(11.3%). The median scores for CD-RISC and MSPSS were 73 (IQR: 58–84) and 64 (IQR: 51–
73), respectively, with no sex differences observed for either scores (p= 0.711 [CD-RISC] and 
p= 0.984 [MSPSS]) (Table 2). Thirty-seven (25%) of the study participants were diagnosed 
with major depressive disorder (MDD) (10 [21%] male; 27 [26%] female; p= 0.548). 
Twenty-four individuals (16%) met criteria for alcohol dependence, and of those, 12 (50%) 
were male. Males were signiﬁcantly more likely to exhibit alcohol dependence compared to 
females (p= 0.030). 
 
According to the LEC, 99% of the participants (149/150) had experienced, witnessed or 
learned about a traumatic event (s). A DTS score of zero indicated that either the participant 
had not experienced a traumatic event, or that the traumatic event that was experienced did 
not result in the development of PTSD symptoms. Fifty-three participants (35%) reported zero 
DTS scores, while 97 participants (65%) reported non-zero DTS scores. The median of the DTS 
non-zero scores was 35 (IQR: 17–58). In a joint analysis of association of the potential 
confounders with DTS, none were found to be signiﬁcantly associated with the zero/non-zero 
status of an individual's DTS score. However, three of the potential confounders, namely 
sex, MDD status and level of  social support, were found to contribute signiﬁcantly to 
non-zero DTS score. To this end, males were found to have signiﬁcantly lower DTS scores 
than females (effect= 29%; 95% CI: 1–49%; p= 0.046), while being diagnosed with MDD 
increased DTS score signiﬁcantly (effect= 78%; 95% CI: 25–153%; p= 0.001). In addition, an 
increased level of social support was found to reduce the DTS score signiﬁcantly (effect of 
each additional score on MSPSS scale= 2%; 95% CI: 1–3%; pb 0.001). 
 
3.2 Genotype data and allele frequencies 
All variants were in Hardy–Weinberg equilibrium (5-HTTLPR p= 0.093; DRD2  Taq1A  
p= 0.587; BDNF  Val66Met  p= 1.000). Genotype counts and percentages for each 
polymorphism, in the total study group and stratiﬁed by sex, are provided in Table 3. No 
signiﬁcant differences in genotype and allele frequencies were noted between males and 
females (5-HTTLPR p= 0.977 [genotype] and p= 0.871 [allele]; DRD2 Taq1A p= 0.981 
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[genotype] and p= 0.857 [allele]; BDNF Val66Met p= 0.817 [genotype] and p= 0.594 
[allele]). 
 
3.3 Association of genetic variants with severity of trauma symptoms 
Although the 5-HTTLPR variant was not associated with the non-zero DTS score (p= 
0.444), participants who possessed at least one  5-HTTLPR  S-allele  (dominant  model)  
were  signiﬁcantly  more likely to be scored as ‘zero’ on the DTS scale (odds ratio [OR]= 2.77; 
95% CI: 1.28–5.97; p= 0.012). 
 
An epistatic interaction between BDNF Val66Met and DRD2 Taq1A polymorphisms was 
found to impact non-zero DTS score (p= 0.006). The nature of this signiﬁcant interaction is 
illustrated by box plots of the observed non-zero DTS scores in Fig. 1. It was found that, on 
the background of the BDNF Val66 homozygote, DTS score increased signiﬁcantly with the 
addition of each DRD2 Taq1A A1 allele. However, upon the BDNF Met66 background, the 
DTS score was found to increase signiﬁcantly on addition of each A2 allele. No statistically 
signiﬁcant differences were observed with regard to zero or non-zero status of DTS scores 
between the genotypes or alleles comprising the individual DRD2 Taq1A or BDNF Val66Met 
polymorphisms. 
 
4. Discussion 
The study group was found to exhibit a current PTSD prevalence of 11.3%, which is 
considerably higher than the 12-month and lifetime prevalence rates observed in the 
recently conducted SASH study (Herman et al., 2009), indicating that the population is 
indeed at increased risk for developing the disorder. 
 
We found that individuals possessing the 5-HTTLPR LL genotype were signiﬁcantly more 
likely to have a non-zero DTS score compared to those who possessed at least one S allele. In 
the present study, a score of ‘zero’ on the DTS indicated either that the individual had not 
experienced a traumatic event that had signiﬁcantly impacted their life, or that, although the 
individual had experienced a traumatic event (s), it had not resulted in any PTSD symptoms. 
Only one participant in the present study indicated that they had not experienced any 
traumatic event. This ﬁnding therefore suggests that those individuals who possessed at least 
one S allele were more resilient to the effects of trauma compared to those carrying the LL 
genotype. Although the S allele has been found to be associated with reduced resilience in a 
recent study (Stein et al., 2009), the L-allele has also been found to be associated with 
reduced resilience in subjects with insecure attachment (Olsson et al., 2005) and those who 
had been exposed to early adversity (Carli et al., 2011; Laucht et al., 2009). Given the 
inconsistent results in publications investigating resilience and 5-HTTLPR, the current study 
needs to be replicated in a larger sample in order to validate the results presented here and 
to better understand the relationship between the two variables. 
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To our knowledge, this is the ﬁrst published study to suggest a role for epistatic interaction 
between the DRD2 Taq1A and BDNF Val66Met polymorphisms in the severity of PTSD 
symptoms. We found that, on a background of the BDNF Val66Val genotype, DTS score 
increased signiﬁcantly with the addition of each DRD2 Taq1A A1 allele.  
 
 
 
Interestingly, however, on the background of the BDNF Val66Met/Met66Met (Met66+) 
genotype,  DTS  score  increased  signiﬁcantly  with  each additional DRD2 Taq1A A2 allele. 
Although neither of the genetic variants was found to contribute to PTSD symptom severity 
individually in the present study, prior research has suggested the involvement of the A1 allele 
in the aetiology of PTSD (Comings et al., 1996; Young et al., 2002), although Young et al. 
(2002) only observed this association in individuals who exhibited harmful drinking. Given the 
role of BDNF in a number of crucial processes in the CNS, mounting evidence suggests that 
BDNF may also play a role in the development of PTSD. However, to date, only three published 
studies have investigated the role of BDNF Val66Met in the aetiology of the disorder, all 
yielding negative results (Lee et al., 2006; Valente et al., 2011; Zhang et al., 2006). 
 
It is perhaps not surprising that the BDNF and DRD2 polymorphisms were found to interact to 
inﬂuence DTS score in the present study, since BDNF has previously been found to be 
involved in the modulation, maintenance and normal functioning of mesolimbic dopaminergic 
neurotransmission (Berton et al., 2006; Bustos et al., 2004; Goggi et al., 2003; Hunnerkopf et 
al., 2007) and in the development of dopaminergic neurons (Baquet et al., 2005; Trzaska et al., 
2009). In Fig. 1, it is noteworthy that the inﬂuence of epistatic interaction between BDNF 
Val66Met and DRD2 Taq1A polymorphisms on DTS score approximates an inverted U-
shaped curve. This observation may be best explained by previous research indicating that 
dopamine functions within a range of optimal concentrations to affect certain brain functions; 
for example, both too much dopamine and too little dopamine have been found to impair 
cognitive functionality (Cools and D'Esposito, 2011; Goldman-Rakic et al., 2000). This U-
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shaped function of dopamine has previously been thought to be due to alterations in dopamine 
D1 receptor activity (Cools and D'Esposito, 2011; Seamans and Yang, 2004), but it has 
recently been reported that DRD2 activation also affects dopamine concentrations in a non-
linear fashion, and that an optimal range of DRD2 activity exists to facilitate adequate brain 
functioning (Gjedde et al., 2010; Monte-Silva et al., 2009). Notably, DRD2 Taq1A has also 
been implicated in affecting the amount of available dopamine in various regions of the 
brain during feedback-guided learning (Cohen et al., 2007), implicating this variant in the U-
shaped effect that dopamine has on certain brain functionality. Although the precise 
relationship between BDNF Val66Met and DRD2 Taq1A variants is yet to be elucidated, it has 
been postulated that a reduction in BDNF expression results in reduced dopaminergic activity 
in the mesolimbic pathways leading to the anterior cingulate cortex (ACC) (Koven and Carr, 
2012). 
 
Given the aforementioned information and from the results obtained in the present study, 
it is tempting to speculate that the BDNF Val66Met genotype drives the U-shaped 
functionality of dopamine in the context of PTSD symptom severity. In other words, an 
increased BDNF activity-dependent secretion (due to the genotype Val66Val (Egan et al., 
2003)) may, together with the reduced DRD2 expression caused by the DRD2 Taq1A 
A1/A1 genotype (Jonsson et al., 1999; Noble et al., 1991; Pohjalainen et al., 1998; Ritchie 
and Noble, 2003; Thompson et al., 1997), cause a signiﬁcant increase in dopaminergic 
concentration. On the other hand, the reduced BDNF activity-dependent secretion (due to 
Met66-containing genotypes (Egan et al., 2003)) and the increased DRD2 expression (due 
to the DRD2 Taq1A A2/A2 genotype (Jonsson et al., 1999; Noble et al., 1991; Pohjalainen et 
al., 1998; Ritchie and Noble, 2003; Thompson et al., 1997)) may, together, signiﬁcantly 
reduce dopaminergic concentration. The epistatic interactions between the two genes may 
therefore render the dopaminergic levels sub-optimal for cognitive functions that impact 
PTSD symptom severity. 
 
Epistasis between the BDNF Val66Met and DRD2 Taq1A variants has previously been 
observed in the context of personality dimensions of harm avoidance and novelty seeking 
(Montag et al., 2010a) and alexithymia (Walter et al., 2011), and volume in the ACC (Montag 
et al., 2010b). Montag et al. (2010a) found that healthy individuals who possessed at least one 
Met66 and one A1 allele (Met66+/A1+ combination) exhibited signiﬁcantly increased scores 
on the Harm Avoidance scale and signiﬁcantly reduced scores on the Novelty Seeking scale. In a 
separate publication by the same group, the same combination of DRD2/BDNF genotypes 
was found to be associated with signiﬁcantly reduced grey matter volume in the ACC (Montag et 
al., 2010b). Individuals with the Met66+/A1+ genotype combination have also been found to 
be more likely to exhibit increased levels of alexithymia (Walter et al., 2011), a personality 
construct that involves difﬁculties in identifying emotional states, and an inability to 
verbalise one's own emotions (Larsen et al., 2003). Interestingly, both increased levels of 
alexithymia (Declercq et al., 2010) and reduced ACC volume (Kasai et al., 2008; Kitayama et 
al., 2006; Thomaes et al., 2010; Woodward et al., 2006) have been observed in PTSD patients. 
http://repository.uwc.ac.za
 12 
 
Therefore, the interaction between DRD2 and BDNF may increase the risk of developing PTSD 
by reducing ACC volume and increasing symptoms of alexithymia observed in PTSD. 
 
4.1. Study limitations 
A number of limitations in the present study deserve mention. The study group size of 150 
participants is relatively small; consequently, the  present  results  require  validation  in  
studies  comprising  larger sample sizes, which will impart greater power. In addition, 
population stratiﬁcation was not controlled for, which may have confounded results. The 
South African Coloured population has a unique mixed ancestry dating back almost 300 
years and comprises a number of different ethnicities, including European Caucasoid, 
Asian, Khoi, San and Black African (Nurse et al., 1985). Since the admixture occurred 
several generations ago, the population has been suggested to be relatively genetically 
homogenous. In a recent study in which 25 unlinked markers were genotyped in a 
South African Coloured population comprising 351 TB cases and 360 controls, no 
signiﬁcant population stratiﬁcation was observed (Barreiro et al., 2006). However, in a 
subsequent study, de Wit et al. (2010) observed substantial genetic heterogeneity within 
the South African Coloured population. Future studies should thus include measures to 
correct for population stratiﬁcation within the South African Coloured population. 
 
It must also be noted that multiple testing was not corrected for, primarily due to the 
exploratory nature of the present study. In addition, the most appropriate means of 
correcting for multiple testing remains contentious and applying Bonferroni's  correction  
may  be too conservative in cases where there is prior evidence that such associations may 
be present. 
 
In light of the exploratory nature of the study, it was decided to limit the genetic analysis 
of the serotonin transporter to one polymorphism, namely 5-HTTLPR. However, the 
authors are mindful of the presence of  additional  polymorphisms  within  the  gene  (such 
as rs25331 (Hu et al., 2006) and rs25532 (Wendland et al., 2008)) that may modulate 
the functionality of 5-HTTLPR. Investigating these polymorphisms will form an important 
aspect of future validation studies. 
 
It is possible that other gene variants may mediate the interaction between the BDNF 
Val66Met and DRD2 Taq1A polymorphisms. For example, the catechol-O-
methyltransferase (COMT) Val158Met variant has been found to alter the functionality of 
COMT, which is an important regulator of dopaminergic neurotransmission, and has also 
been found to be involved in reduction in ACC volume in patients with PTSD (Schulz-
Heik et al., 2011). Future studies should thus include additional variants, such as COMT 
Val158Met. 
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Finally, the aetiology of psychiatric disorders, and particularly PTSD, involves a large 
environmental component, thought to interact with the genetic component. It is 
therefore important that future studies take environmental factors into account. 
 
5. Conclusions 
The preliminary results yielded in the present study implicate the interaction between genes 
encoding BDNF and DRD2 in the severity of PTSD symptoms. As mentioned, the present 
results require validation in a larger study group, while accounting for environmental factors 
that may contribute to the development of PTSD, and possible population stratification. If 
the present results are validated, further work will be required to determine the mechanism 
of action of the interaction between BDNF and DRD2. These results could have important 
implications for novel therapeutic regimes with which to treat this debilitating psychiatric 
disorder. 
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